These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
440 related articles for article (PubMed ID: 9815857)
1. Optimal scheduling of interleukin 12 and chemotherapy in the murine MB-49 bladder carcinoma and B16 melanoma. Teicher BA; Ara G; Buxton D; Leonard J; Schaub RG Clin Cancer Res; 1997 Sep; 3(9):1661-7. PubMed ID: 9815857 [TBL] [Abstract][Full Text] [Related]
2. Optimal scheduling of interleukin-12 and fractionated radiation therapy in the murine Lewis lung carcinoma. Teicher BA; Ara G; Buxton D; Leonard J; Schaub RG Radiat Oncol Investig; 1998; 6(2):71-80. PubMed ID: 9572683 [TBL] [Abstract][Full Text] [Related]
3. Interleukin-12 immunotherapy of murine transitional cell carcinoma of the bladder: dose dependent tumor eradication and generation of protective immunity. O'Donnell MA; Luo Y; Hunter SE; Chen X; Hayes LL; Clinton SK J Urol; 2004 Mar; 171(3):1330-5. PubMed ID: 14767343 [TBL] [Abstract][Full Text] [Related]
4. Synergistic effects of combination therapy with human recombinant interleukin-2 and tumor necrosis factor in murine tumor models. Winkelhake JL; Stampfl S; Zimmerman RJ Cancer Res; 1987 Aug; 47(15):3948-53. PubMed ID: 3496953 [TBL] [Abstract][Full Text] [Related]
5. [Complete remission of bladder cancer with multiple pulmonary metastases obtained by combined chemotherapy with cis-platinum, adriamycin and cyclophosphamide]. Takigawa H; Odachi M; Kagawa S; Kurokawa K Gan To Kagaku Ryoho; 1985 Sep; 12(9):1877-9. PubMed ID: 4041165 [TBL] [Abstract][Full Text] [Related]
6. A metronomic schedule of cyclophosphamide combined with PEGylated liposomal doxorubicin has a highly antitumor effect in an experimental pulmonary metastatic mouse model. Shiraga E; Barichello JM; Ishida T; Kiwada H Int J Pharm; 2008 Apr; 353(1-2):65-73. PubMed ID: 18155369 [TBL] [Abstract][Full Text] [Related]
7. Enhanced antitumor immune responses of IL-2 gene-modified tumor vaccine by combination with IL-1 and low dose cyclophosphamide. Cao X; Zhang W; Wan T; Yu Y; Tao Q; Wang J J Exp Clin Cancer Res; 1999 Jun; 18(2):173-9. PubMed ID: 10464704 [TBL] [Abstract][Full Text] [Related]
8. Modulation of hematologic and immunologic effects of high dose chemotherapy by interleukin-2 in a murine tumor model. Rinehart JJ; Triozzi PL; Lee MH; Aldrich W; Young D Mol Biother; 1992 Jun; 4(2):77-82. PubMed ID: 1515098 [TBL] [Abstract][Full Text] [Related]
9. Augmentation of antitumor efficacy by the combination of recombinant tumor necrosis factor and chemotherapeutic agents in vivo. Krosnick JA; Mulé JJ; McIntosh JK; Rosenberg SA Cancer Res; 1989 Jul; 49(14):3729-33. PubMed ID: 2736513 [TBL] [Abstract][Full Text] [Related]
10. The effect of interleukin 12 desensitization on the antitumor efficacy of recombinant interleukin 12. Coughlin CM; Wysocka M; Trinchieri G; Lee WM Cancer Res; 1997 Jun; 57(12):2460-7. PubMed ID: 9192826 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness of long-term chemotherapy and/or BCG on murine bladder cancer. Soloway MS Natl Cancer Inst Monogr; 1978 Dec; (49):327-32. PubMed ID: 748788 [TBL] [Abstract][Full Text] [Related]
12. Effect of murine alpha-, beta-, and gamma-interferons in combination with alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, on the tumor growth and metastasis of B16 melanoma and Lewis lung carcinoma in mice. Sunkara PS; Bowlin TL; Rosenberger AL; Fleischmann WR J Biol Response Mod; 1989 Apr; 8(2):170-9. PubMed ID: 2499664 [TBL] [Abstract][Full Text] [Related]
13. Markedly improved efficacy of edatrexate compared to methotrexate in a high-dose regimen with leucovorin rescue against metastatic murine solid tumors. Sirotnak FM; Otter GM; Schmid FA Cancer Res; 1993 Feb; 53(3):587-91. PubMed ID: 8425192 [TBL] [Abstract][Full Text] [Related]
14. Immune regulation of metastasis from in vivo derived syngeneic murine melanoma. Harning R; Koo GC; Szalay J Reg Immunol; 1990; 3(2):97-102. PubMed ID: 1965137 [TBL] [Abstract][Full Text] [Related]
15. Immunopharmacological and antitumor effects of second-generation immunomodulatory oligonucleotides containing synthetic CpR motifs. Wang D; Li Y; Yu D; Song SS; Kandimalla ER; Agrawal S Int J Oncol; 2004 Apr; 24(4):901-8. PubMed ID: 15010828 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic experience of advanced urothelial tract tumors. Nakada T; Akiya T; Yoshikawa M; Umeda K; Katayama T Hinyokika Kiyo; 1985 Apr; 31(4):601-6. PubMed ID: 4041118 [TBL] [Abstract][Full Text] [Related]
17. [Effect of combination chemotherapy of nitrosourea MCNU with various anti-tumor agents]. Ninomiya K; Sekido S; Araki T Gan To Kagaku Ryoho; 1984 Jun; 11(6):1315-23. PubMed ID: 6428326 [TBL] [Abstract][Full Text] [Related]
18. Cancer immunotherapy with interleukin 12 and granulocyte-macrophage colony-stimulating factor-encapsulated microspheres: coinduction of innate and adaptive antitumor immunity and cure of disseminated disease. Hill HC; Conway TF; Sabel MS; Jong YS; Mathiowitz E; Bankert RB; Egilmez NK Cancer Res; 2002 Dec; 62(24):7254-63. PubMed ID: 12499267 [TBL] [Abstract][Full Text] [Related]
19. Combination of IL-12 gene therapy and CTX chemotherapy inhibits growth of primary B16(F10) melanoma tumors in mice. Mitrus I; Delić K; Wróbel N; Missol-Kolka E; Szala S Acta Biochim Pol; 2006; 53(2):357-60. PubMed ID: 16733559 [TBL] [Abstract][Full Text] [Related]
20. [Combination chemotherapy of advanced transitional cell carcinoma with cis-platinum, cyclophosphamide, adriamycin and 5-fluorouracil (CISCAF)]. Fujioka H; Tada Y; Nakano E; Matsuda M; Osafune M; Sagawa S; Takaha M; Sonoda T Gan To Kagaku Ryoho; 1984 Aug; 11(8):1612-6. PubMed ID: 6541019 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]